The report covers a forecast and an analysis of the viral clearance market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the viral clearance market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the viral clearance market on global and regional levels.
In order to give the users of this report a comprehensive view of the viral clearance market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein method, application, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the viral clearance market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the viral clearance market on a global and regional basis.
The study provides a decisive view of the viral clearance market by segmenting the market based on method, application, end-user, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The method segment is classified into viral removal and viral inactivation. By application, this market is segmented into blood and blood products, recombinant proteins, vaccines, and other applications. By end-user, this market includes pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), and other end-users.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes the demand for viral clearance tools based on individual segments and applications in all regions and countries.
The report also includes detailed profiles of various end players, such as Merck KGaA, Wuxi Biologics (Cayman), Charles River Laboratories International Inc., Kedrion, Texcell Inc., Vironova Biosafety, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, and ViruSure GmbH, among others.
This report segments the global viral clearance market as follows:
Global Viral Clearance Market: By Method
- Viral Removal
- Chromatography
- Precipitation
- Nanofiltration
- Viral Inactivation
- Low pH
- Solvent Detergent Method
- Pasteurization
- Other Viral Inactivation Methods
Global Viral Clearance Market: By Application
- Blood and Blood Products
- Recombinant Proteins
- Vaccines
- Other Applications (Stem Cell Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, etc.)
Global Viral Clearance Market: By End-User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Other End-Users
Global Viral Clearance Market: By Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
